Status:
COMPLETED
Study of Patients With Knee Prostheses Treated With Noninvasive Neuromodulation
Lead Sponsor:
University of Las Palmas de Gran Canaria
Conditions:
Knee Prosthesis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
It will consist of a randomized clinical trial with a control group. The sample will be distributed as homogeneously as possible into two groups, which will be randomly divided into a control group, t...
Detailed Description
The main objective will be to evaluate the efficacy of the NESA XSignal device in relation to the improvement of pain, functionality and quality of life in patients who have undergone total knee repla...
Eligibility Criteria
Inclusion
- Patients over 18 years of age
- Total knee replacement surgery at the Hospital San Juan de Dios de Tenerife.
- Be able to freely consent to take part in the study.
Exclusion
- No contraindications for treatment with NXSignal: pacemakers, internal bleeding, poor skin condition with ulcerations or wounds, acute febrile processes, acute thrombophlebitis and/or electricity phobia.
- Patients with total knee prosthesis of more than 3 months of evolution.
- Patients with total knee prosthesis with complications.
Key Trial Info
Start Date :
November 11 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06134999
Start Date
November 11 2023
End Date
July 31 2025
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
José Carlos del Castillo Rodríguez
Santa Cruz de Tenerife, Santa Cruz De Tenerife, Spain, 38009